Juvenescence®

Juvenescence® company information, Employees & Contact Information

Explore related pages

Related company profiles:

Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan. The Juvenescence team consists of highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in pharmaceutical drug development, synthetic biology, and tissue and cellular engineering. Juvenescence has a broad pipeline in development and is driving innovation, with a focus on discovering and developing these therapies to modify the aging process, through prevention and by regenerating damage, to support healthy aging and increase health span.

Company Details

Employees
33
Founded
-
Address
Viking House, St Paul's Square, 1st Floor,isle Of Man
Phone
441624639396
Email
ch****@****nce.ltd
Industry
Biotechnology
HQ
Ramsey
Looking for a particular Juvenescence® employee's phone or email?

Juvenescence® Questions

News

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42 - GlobeNewswire

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42 GlobeNewswire

Serina Therapeutics Congratulates Juvenescence on Securing $150 Million Series B Financing and Strategic Alliance with M42 - Nasdaq

Serina Therapeutics Congratulates Juvenescence on Securing $150 Million Series B Financing and Strategic Alliance with M42 Nasdaq

Juvenescence enhances AI drug discovery with Ro5 acquisition - Pharmaceutical Technology

Juvenescence enhances AI drug discovery with Ro5 acquisition Pharmaceutical Technology

Juvenescence Secures $76M in Series B-1 Financing Led by M42 to Accelerate AI-Driven Drug Development - PharmiWeb.com

Juvenescence Secures $76M in Series B-1 Financing Led by M42 to Accelerate AI-Driven Drug Development PharmiWeb.com

M42 enters R&D with investment in longevity firm Juvenescence - BioWorld MedTech

M42 enters R&D with investment in longevity firm Juvenescence BioWorld MedTech

Abu Dhabi’s M42 Invests In Longevity Startup Juvenescence - Bloomberg

Abu Dhabi’s M42 Invests In Longevity Startup Juvenescence Bloomberg

Juvenescence acquires AI drug discovery company Ro5 to - GlobeNewswire

Juvenescence acquires AI drug discovery company Ro5 to GlobeNewswire

Juvenescence acquires AI drug discovery company Ro5 - The Pharma Letter

Juvenescence acquires AI drug discovery company Ro5 The Pharma Letter

AI Meets longevity: Juvenescence acquires drug discovery firm Ro5 - BioXconomy

AI Meets longevity: Juvenescence acquires drug discovery firm Ro5 BioXconomy

M42 and Juvenescence collaborate on AI-enabled longevity drugs - Longevity.Technology

M42 and Juvenescence collaborate on AI-enabled longevity drugs Longevity.Technology

M42 makes strategic investment in Juvenescence and forms partnership to develop therapeutics for age-related diseases - مكتب أبوظبي الإعلامي

M42 makes strategic investment in Juvenescence and forms partnership to develop therapeutics for age-related diseases مكتب أبوظبي الإعلامي

Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership - GlobeNewswire

Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership GlobeNewswire

M42 announces strategic investment and partnership with leading biotech Juvenescence - ZAWYA

M42 announces strategic investment and partnership with leading biotech Juvenescence ZAWYA

Enterprise — Essential business, finance and policy news from the Arab world - enterprise.news

Enterprise — Essential business, finance and policy news from the Arab world enterprise.news

Abu Dhabi's M42 partners with UK firm to develop AI-driven therapeutics for age-related diseases - Khaleej Times

Abu Dhabi's M42 partners with UK firm to develop AI-driven therapeutics for age-related diseases Khaleej Times

Juvenescence Cuts Stake in AgeX Therapeutics - 24/7 Wall St.

Juvenescence Cuts Stake in AgeX Therapeutics 24/7 Wall St.

The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease - PR Newswire

The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease PR Newswire

Juvenescence Now Owns 78.70% of AgeX Therapeutics (AGE) - Nasdaq

Juvenescence Now Owns 78.70% of AgeX Therapeutics (AGE) Nasdaq

Juvenescence Debuts New Product to Aid in Supporting a Healthy Metabolism - PR Newswire

Juvenescence Debuts New Product to Aid in Supporting a Healthy Metabolism PR Newswire

British billionaire Jim Mellon plans to take his life extension start-up public in six to 12 months - CNBC

British billionaire Jim Mellon plans to take his life extension start-up public in six to 12 months CNBC

Juvenescence partners with NorthStar SailGP team to champion health, wellness and longevity - SailGP

Juvenescence partners with NorthStar SailGP team to champion health, wellness and longevity SailGP

Juvenescence debuts ketosis-triggering drink that supports healthy aging - Longevity.Technology

Juvenescence debuts ketosis-triggering drink that supports healthy aging Longevity.Technology

Juvenescence raises $100M to fund longevity assets to early readouts - Fierce Biotech

Juvenescence raises $100M to fund longevity assets to early readouts Fierce Biotech

Juvenescence appoints Chief Scientific Officer, Dr Grazia Piizzi - Longevity.Technology

Juvenescence appoints Chief Scientific Officer, Dr Grazia Piizzi Longevity.Technology

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement - Business Wire

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement Business Wire

Juvenescence bags $50M to advance anti-aging projects - Fierce Biotech

Juvenescence bags $50M to advance anti-aging projects Fierce Biotech

First molecules discovered by next-generation artificial intelligence to be developed into drugs - EurekAlert!

First molecules discovered by next-generation artificial intelligence to be developed into drugs EurekAlert!

Mubadala Investment-backed M42 invests in Juvenescence - pehub.com

Mubadala Investment-backed M42 invests in Juvenescence pehub.com

Purpose-driven longevity fund launches in face of regulatory issues - BioWorld MedTech

Purpose-driven longevity fund launches in face of regulatory issues BioWorld MedTech

Insilico, Juvenescence and the Buck Institute form AI-based venture to tackle metabolism and aging-related diseases - Fierce Biotech

Insilico, Juvenescence and the Buck Institute form AI-based venture to tackle metabolism and aging-related diseases Fierce Biotech

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results - Yahoo Finance

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results Yahoo Finance

Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine - BioSpace

Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine BioSpace

Morphoceuticals showcase successful limb regeneration in frogs - World Business Outlook

Morphoceuticals showcase successful limb regeneration in frogs World Business Outlook

Study shows effectiveness of Juvenescence’s ketosis-inducing supplement - NutraIngredients.com

Study shows effectiveness of Juvenescence’s ketosis-inducing supplement NutraIngredients.com

LyGenesis Closes $3 Million Series A Financing to Advance Its Organ Regeneration Technology to the Clinic - PR Newswire

LyGenesis Closes $3 Million Series A Financing to Advance Its Organ Regeneration Technology to the Clinic PR Newswire

Juvenescence targets fibrotic disease with new investment - Longevity.Technology

Juvenescence targets fibrotic disease with new investment Longevity.Technology

Juvenescence onboards Dr Richard Marshall CBE as CEO - World Business Outlook

Juvenescence onboards Dr Richard Marshall CBE as CEO World Business Outlook

Pitt biotech spinout raises $3M - The Business Journals

Pitt biotech spinout raises $3M The Business Journals

Buck Institute, Insilico Med and Juvenescence Found Napa Therapeutics to Focus on Age-Related Diseases - BioSpace

Buck Institute, Insilico Med and Juvenescence Found Napa Therapeutics to Focus on Age-Related Diseases BioSpace

Longevity And Anti-Senescence Therapy Market Hits New High | Major Giants CohBar, Elevian, FoxBio - openPR.com

Longevity And Anti-Senescence Therapy Market Hits New High | Major Giants CohBar, Elevian, FoxBio openPR.com

AI And Biotech Companies In The East And West Invest In Combating Aging - Forbes

AI And Biotech Companies In The East And West Invest In Combating Aging Forbes

Here's What AgeX Therapeutics, Inc.'s (NYSEMKT:AGE) Shareholder Ownership Structure Looks Like - simplywall.st

Here's What AgeX Therapeutics, Inc.'s (NYSEMKT:AGE) Shareholder Ownership Structure Looks Like simplywall.st

Jim Mellon’s biotech Juvenescence raises $50m for anti-ageing therapies - PMLiVE

Jim Mellon’s biotech Juvenescence raises $50m for anti-ageing therapies PMLiVE

Abu Dhabi’s M42 Acquires Stake in Longevity Biotech Firm Juvenescence - UPPERNEWS

Abu Dhabi’s M42 Acquires Stake in Longevity Biotech Firm Juvenescence UPPERNEWS

Shane Warne’s youngest daughter reveals shock new career move - Herald Sun

Shane Warne’s youngest daughter reveals shock new career move Herald Sun

Top Juvenescence® Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant